LISANDRA MEJIA: Open Payments
NPI 1114643277 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,718 in 62 payments from 9 companies in 2025. Trend: 2023 $364 · 2024 $824 · 2025 $1,718
Food & beverage: $1,059Consulting: $560Education: $99
| Company | Payments | Amount |
|---|---|---|
| Celltrion USA Inc. | 7 | $643 |
| ABBVIE INC. | 33 | $458 |
| Janssen Biotech, Inc. | 7 | $232 |
| Janssen Scientific Affairs, LLC | 3 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $108 |
| Becton, Dickinson and Company | 2 | $71 |
| Lilly USA, LLC | 3 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| PFIZER INC. | 1 | $15 |
Products named: TREMFYA, SKYRIZI, RINVOQ, ENTYVIO, VEGZELMA, HemoSphere, OMVOH, XIFAXAN.
Industry payments across FL — which companies pay providers there.
